An Update on the Diagnosis and Management of Inflammatory Bowel Disease
A special issue of Diagnostics (ISSN 2075-4418). This special issue belongs to the section "Pathology and Molecular Diagnostics".
Deadline for manuscript submissions: 31 December 2024 | Viewed by 73
Special Issue Editors
Interests: inflammatory bowel disease; ulcerative colitis; Crohn’s disease; gastrointestinal tuberculosis; acute pancreatitis; chronic pancreatitis
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Inflammatory bowel disease (IBD) is a chronic disease of the intestine with significant morbidity and impact on quality of life. It is now recognized as a global disease, with a rising disease prevalence across different countries. The exact etiology of the disease is unclear. There are defective immune responses to environmental antigens and the gut microbiota in genetically predisposed individuals. An early diagnosis of the disease is essential for the initiation of therapy at an early stage. However, its nonspecific symptoms and diagnostic confusion with IBD mimics can result in a diagnostic delay. Our therapeutic armamentarium has been rapidly increasing over the years. Conventional drugs like steroids and thiopurines have stood the test of time. Newer drugs, including biological agents and small molecules with different mechanisms of action, have been tested with fair rates of response and remission. It is vital that we identify the right approach to diagnosis, as well as the right drugs for use in each scenario.
The purpose of this Special Issue is to provide all the latest information related to the diagnosis and management of patients with inflammatory bowel disease. This will provide important information to help clinicians improve their decisions in not only the diagnosis but also the management of this disease.
Dr. Vishal Sharma
Dr. Anuraag Jena
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diagnostics is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- ulcerative colitis
- Crohn’s disease
- anti-TNF
- small molecules
- bowel ultrasound
- colonoscopy
- CT enterography
- biologicals
- anti-integrins
